Source: MarketScreener

Soligenix: Soligenix to Present at the LD Micro Conference

(marketscreener.com) PRINCETON, N.J., Aug. 27, 2020 /PRNewswire/ -- Soligenix, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its Senior Vice President and Chief Financial Officer, Jonathan Guarino, will deliver a corporate...https://www.marketscreener.com/news/Soligenix-to-Present-at-the-LD-Micro-Conference--31187310/?utm_medium=RSS&utm_content=20200827

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Christopher J. Schaber's photo - President & CEO of Soligenix

President & CEO

Christopher J. Schaber

CEO Approval Rating

68/100

Soligenix develops and commercializes biotherapeutics for the treatment of gastrointestinal disorders, inflammation and oncology diseases. Read more